van de Griend RJ[au] - Search Results

Year	Number of Results
1977	1
1978	1
1980	1
1981	5
1982	7
1983	3
1984	4
1985	3
1986	2
1987	6
1988	5
1989	4
1992	2
1993	2
1994	1
2022	0

1

Large-scale purification and cryopreservation of human monocytes.

De Boer M, Reijneke R, Van de Griend RJ, Loos JA, Roos D. De Boer M, et al. Among authors: van de griend rj. J Immunol Methods. 1981;43(2):225-39. doi: 10.1016/0022-1759(81)90027-2. J Immunol Methods. 1981. PMID: 7264325

2

Production of bi-specific monoclonal antibodies in a hollow-fibre bioreactor.

Gorter A, van de Griend RJ, van Eendenburg JD, Haasnoot WH, Fleuren GJ. Gorter A, et al. Among authors: van de griend rj. J Immunol Methods. 1993 May 26;161(2):145-50. doi: 10.1016/0022-1759(93)90289-j. J Immunol Methods. 1993. PMID: 8505544

3

Changes in human T lymphocytes after thymectomy and during senescence.

Van de Griend RJ, Carreno M, Van Doorn R, Leupers CJ, Van den Ende A, Wijermans P, Oosterhuis HJ, Astaldi A. Van de Griend RJ, et al. J Clin Immunol. 1982 Oct;2(4):289-95. doi: 10.1007/BF00915069. J Clin Immunol. 1982. PMID: 6216263

4

Enzyme analysis of lymphoproliferative diseases: a useful addition to cell surface phenotyping.

van de Griend RJ, van der Reijden HJ, Bolhuis RL, Melief CJ, von dem Borne AE, Roos D. van de Griend RJ, et al. Blood. 1983 Sep;62(3):669-76. Blood. 1983. PMID: 6309282 Free article.

5

Functional reactivity of WT31 monoclonal antibody with T cell receptor-gamma expressing CD3+4-8- T cells.

van de Griend RJ, Borst J, Tax WJ, Bolhuis RL. van de Griend RJ, et al. J Immunol. 1988 Feb 15;140(4):1107-10. J Immunol. 1988. PMID: 2449496

6

Subpopulations of T lymphocytes from human blood differing in density and stage of maturation.

van de Griend RJ, Astaldi GC, van den Ende A, Loos JA, Roos D. van de Griend RJ, et al. Eur J Immunol. 1980 Jan;10(1):70-3. doi: 10.1002/eji.1830100114. Eur J Immunol. 1980. PMID: 6244964

7

Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells.

Van Dijk J, Tsuruo T, Segal DM, Bolhuis RL, Colognola R, van de Griend RJ, Fleuren GJ, Warnaar SO. Van Dijk J, et al. Among authors: van de griend rj. Int J Cancer. 1989 Oct 15;44(4):738-43. doi: 10.1002/ijc.2910440431. Int J Cancer. 1989. PMID: 2793246

8

Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.

Gorter A, Krüse KM, Schrier PI, Fleuren GJ, van de Griend RJ. Gorter A, et al. Among authors: van de griend rj. Clin Exp Immunol. 1992 Jan;87(1):111-6. doi: 10.1111/j.1365-2249.1992.tb06422.x. Clin Exp Immunol. 1992. PMID: 1531120 Free PMC article.

9

Coordinated V gamma and V delta gene segment rearrangements in human T cell receptor gamma/delta+ lymphocytes.

Sturm E, Braakman E, Bontrop RE, Chuchana P, Van de Griend RJ, Koning F, Lefranc MP, Bolhuis RL. Sturm E, et al. Among authors: van de griend rj. Eur J Immunol. 1989 Jul;19(7):1261-5. doi: 10.1002/eji.1830190717. Eur J Immunol. 1989. PMID: 2547624

10

Killing of autologous B-lineage malignancy using CD3 x CD19 bispecific monoclonal antibody in end stage leukemia and lymphoma.

Haagen IA, Geerars AJ, de Lau WB, Clark MR, van de Griend RJ, Bast BJ, de Gast BC. Haagen IA, et al. Among authors: van de griend rj. Blood. 1994 Jul 15;84(2):556-63. Blood. 1994. PMID: 7517719 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results